WAVD Overview

Merger and Strategic Goals: Firefly Neuroscience has successfully completed its merger with WaveDancer, Inc., positioning itself to enhance patient outcomes in mental health through its AI-driven Brain Network Analytics (BNA™) technology, which aims for commercialization by 2025.

Collaborations and Future Plans: The company is focusing on partnerships with CNS drug developers and leveraging its extensive database to improve diagnostic accuracy and treatment pathways for brain health disorders, while also reducing costs and expediting drug development processes.

Merger and Strategic Focus: Firefly Neuroscience has successfully closed its merger with WaveDancer, which enhances its capacity to commercialize its FDA-cleared Brain Network Analytics (BNA™) technology aimed at improving diagnoses and treatments for mental health disorders.

Partnerships and Future Plans: The company is collaborating with major CNS drug companies like Novartis and Takeda to advance new treatment developments, while also planning to make BNA™ available to neurologists in 2025, leveraging its extensive patient database for better clinical outcomes.

Merger and Strategic Focus: Firefly Neuroscience has successfully completed its merger with WaveDancer, Inc., positioning itself to enhance brain health outcomes through its AI-driven Brain Network Analytics (BNA™) technology, which aims to improve diagnosis and treatment for mental illnesses and neurological disorders.

Commercialization Plans: The company plans to commercially launch BNA™ in 2025, targeting neurologists and CNS drug companies, while leveraging its extensive database of patient data to advance clinical research and optimize patient care pathways.

Merger Announcement: Firefly Neuroscience, Inc. has successfully merged with WaveDancer, Inc., and will begin trading under the ticker symbol 'AIFF' on Nasdaq starting August 13, 2024.

Technology Focus: The company aims to enhance brain health treatment through its AI-driven Brain Network Analytics (BNA) platform, which has already conducted over 77,000 brain scans and is designed to improve diagnosis and treatment for mental illnesses and neurological disorders.

Reverse Stock Split Announcement: WaveDancer, Inc. will execute a reverse stock split at a ratio of 1-for-3 effective August 12, 2024, and will change its name to Firefly Neuroscience, Inc., with trading under the new symbol AIFF starting August 13, 2024.

Company Focus and Future Plans: Firefly Neuroscience is dedicated to advancing diagnostic and treatment technologies for mental health issues through its Brain Network Analytics software platform, following the merger with WaveDancer.